– January 1, 2013
January 1, 2013
View Archives Issues
-
Radioembolization for Neuroendocrine Liver Metastases: Safety, Imaging, and Long-Term Outcomes
In a retrospective series, 40 patients with liver-dominant metastatic neuroendocrine tumors were treated with 90Y radioembolization between 2003 and 2007 at a single institution. Response to therapy was assessed by World Health Organization (WHO) guidelines for size and European Association for the Study of the Liver disease (EASL) guidelines for necrosis. -
An Increased Risk of Non-Hodgkin Lymphoma in Chronic Fatigue Syndrome Patients
Chronic fatigue syndrome (CFS) is common in community practice and it has been speculated that it is the result of chronic immune proliferation or infection. In a review of Surveillance, Epidemiology, and End Results registry data, coupled with Medicare claims data, an association of CFS with non-Hodgkin lymphoma is clearly demonstrated. -
Vaccination Considerations for Chemotherapy Patients
A 58-year-old female patient with non-Hodgkin lymphoma is seen in the medical oncology clinic for the initiation of the fourth cycle of chemotherapy (R-CHOP). She had presented approximately 3 months earlier with asymptomatic lymphadenopathy. Computerized tomography revealed enlarged lymph nodes throughout the chest and abdomen and an axillary node biopsy revealed follicular large B-cell lymphoma. -
Stress and Poor Cancer Outcomes: It’s More Than Psychological
Chronic stress has been associated with development of several diseases and the release of several cytokines and growth factors known to support cancer growth and metastases. Pharmacological agents targeting the stress response, such as beta-blockers and prostaglandin inhibitors, have been associated with improved survivorship in patients with several solid tumors, including ovarian cancer. The relationship supports prospective clinical investigation, already underway. -
Pharmacology Watch: Zolpidem and Risk of Falls in Hospitalized Patients
Zolpidem and risk of falls; AVR and anticoagulation; statins in cancer patients; and FDA actions. -
Clinical Briefs in Primary Care Supplement